Cargando…
Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design
Recently, many autologous tumor antigens have been examined for their potential use in cancer immunotherapy. However, the success of cancer vaccines in clinical trials has been limited, partly because of the limitations of using single, short peptides in most attempts. With this in mind, we aimed to...
Autores principales: | Wada, Hiroshi, Shimizu, Atsushi, Osada, Toshihiro, Tanaka, Yuki, Fukaya, Satoshi, Sasaki, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029771/ https://www.ncbi.nlm.nih.gov/pubmed/29969453 http://dx.doi.org/10.1371/journal.pone.0199249 |
Ejemplares similares
-
Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design
por: Wada, Hiroshi, et al.
Publicado: (2018) -
TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
por: Tanaka, Yuki, et al.
Publicado: (2020) -
Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
por: Tanaka, Yuki, et al.
Publicado: (2022) -
Dysfunctional immunoproteasomes in autoinflammatory diseases
por: Arimochi, Hideki, et al.
Publicado: (2016) -
Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors
por: Besse, Andrej, et al.
Publicado: (2022)